Suppressive effects of tea catechins on breast cancer

Nutrients

Volumn 8, Issue 8, 2016, Pages

  Xiang, Li Ping ^a,b   Wang, Ao ^b   Ye, Jian Hui ^a   Zheng, Xin Qiang ^a   Polito, Curt Anthony ^a   Lu, Jian Liang ^a   Li, Qing Sheng ^a   Liang, Yue Rong ^a,b  

^a ZHEJIANG UNIVERSITY   (China)

^b National Tea and Tea product Quality Supervision and Inspection Center (Guizhou)   (China)

Author keywords

Anti proliferation; Anticancer; Antioxidant; Camellia sinensis; DNA methylation; Metastasis; Signaling pathway

Indexed keywords

CATALASE; CATECHIN; DIPEPTIDYL CARBOXYPEPTIDASE; DNA METHYLTRANSFERASE; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; FATTY ACID SYNTHASE; GALLOCATECHIN; GLUCOSE REGULATED PROTEIN 78; GLUTATHIONE PEROXIDASE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE B; PROTEIN KINASE FYN; PROTEIN KINASE ZAP 70; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; SURVIVIN; UROKINASE RECEPTOR; VASCULOTROPIN; VASCULOTROPIN C; VASODILATOR STIMULATED PHOSPHOPROTEIN; VIMENTIN; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; ANTIOXIDANT; EPIGALLOCATECOL GALLATE; GALLIC ACID; PLANT EXTRACT; TEA;

ANGIOGENESIS; APOPTOSIS; BREAST CANCER; CANCER CELL; CANCER RISK; CELL PROLIFERATION; DNA DAMAGE; DNA METHYLATION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; METASTASIS; POSTMENOPAUSE; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TEA; ANALOGS AND DERIVATIVES; ANIMAL; BREAST NEOPLASMS; CAMELLIA SINENSIS; CHEMISTRY; DIETARY SUPPLEMENT; EVIDENCE BASED MEDICINE; FEMALE; FOOD HANDLING; FUNCTIONAL FOOD; INTESTINE ABSORPTION; METABOLISM; NEOVASCULARIZATION, PATHOLOGIC; OXIDATION REDUCTION REACTION; PLANT LEAF; REPRODUCIBILITY; RISK;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; BREAST NEOPLASMS; CAMELLIA SINENSIS; CATECHIN; DIETARY SUPPLEMENTS; EVIDENCE-BASED MEDICINE; FEMALE; FOOD HANDLING; FUNCTIONAL FOOD; GALLIC ACID; HUMANS; INTESTINAL ABSORPTION; NEOVASCULARIZATION, PATHOLOGIC; OXIDATION-REDUCTION; PLANT EXTRACTS; PLANT LEAVES; REPRODUCIBILITY OF RESULTS; RISK; TEA;

EID: 85015599215     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu8080458     Document Type: Review

References (94)

1. Stewart, B.W.; Wild, C.P. World Cancer Report 2014;World Health Organization: French, 2014; Chapters 1.1 and 5.2; Available online: http://www.searo.who.int/publications/bookstore/documents/9283204298/en/ (accessed on 20 May 2016).
2. Kushi, L.H.; Doyle, C.; McCullough, M.; Rock, C.L.; Demark-Wahnefried, W.; Bandera, E.V.; Gapstur, S.; Patel, A.V.; Andrews, K.; Gansler, T. American cancer society guidelines on nutrition and physical activity for cancer prevention: Reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J. Clin. 2012, 62, 30-67. [CrossRef] [PubMed]
3. Thomson, C.A. Diet and breast cancer: Understanding risks and benefits. Nutr. Clin. Pract. 2012, 27, 636-650. [CrossRef] [PubMed]
4. Liang, Y.R.; Ye, Q.; Jin, J.; Liang, H.; Lu, J.L.; Du, Y.Y.; Dong, J.J. Chemical and instrumental assessment of green tea sensory preference. Int. Food Prop. 2008, 11, 258-272. [CrossRef]
5. Dong, J.J.; Ye, J.H.; Lu, J.L.; Zheng, X.Q.; Liang, Y.R. Isolation of antioxidant catechins from green tea and its decaffeination. Food Bioprod. Process. 2011, 89, 62-66. [CrossRef]
6. Lin, S.Y.; Chen, Y.L.; Lee, C.L.; Cheng, C.Y.; Roan, S.F.; Chen, I.Z. Monitoring volatile compound profiles and chemical compositions during the process of manufacturing semi-fermented oolong tea. J. Hortic. Sci. Biotechnol. 2013, 88, 159-164. [CrossRef]
7. Liang, Y.R.; Lu, J.L.; Zhang, L.Y.; Wu, S.; Wu, Y. Estimation of black tea quality by analysis of chemical composition and colour difference of tea infusions. Food Chem. 2003, 80, 283-290. [CrossRef]
8. Xu, J.Y.; Wu, L.Y.; Zheng, X.Q.; Lu, J.L.; Wu, M.Y.; Liang, Y.R. Green tea polyphenols attenuating ultraviolet b-induced damage to human retinal pigment epithelial cells in vitro. Invest. Ophthalmol. Vis. Sci. 2010, 51, 6665-6670. [CrossRef] [PubMed]
9. Chen, X.; Lu, W.; Zheng, Y.; Gu, K.; Chen, Z.; Zheng, W.; Shu, X.O. Exercise, tea consumption, and depression among breast cancer survivors. J. Clin. Oncol. 2010, 28, 991-998. [CrossRef] [PubMed]
10. Li, M.; Tse, L.A.; Chan, W.C.; Kwok, C.H.; Leung, S.L.; Wu, C.; Yu, W.C.; Yu, I.T.S.; Yu, C.H.T.; Wang, F. et al. Evaluation of breast cancer risk associated with tea consumption by menopausal and estrogen receptor status among Chinese women in Hong Kong. Cancer Epidemiol. 2016, 40, 73-78. [CrossRef] [PubMed]
11. Suzuki, Y.; Tsubono, Y.; Nakaya, N.; Suzuki, Y.; Koizumi, Y.; Tsuji, I. Green tea and the risk of breast cancer: Pooled analysis of two prospective studies in Japan. Br. J. Cancer 2004, 90, 1361-1363. [CrossRef] [PubMed]
12. Zhang, M.; Holman, C.D.A.J.; Huang, J.P.; Xie, X. Green tea and the prevention of breast cancer: A case-control study in Southeast China. Carcinogenesis 2007, 28, 1074-1078. [CrossRef] [PubMed]
13. Imai, K.; Suga, K.; Nakachi, K. Cancer-Preventive effects of drinking green tea among a Japanese population. Prev. Med. 1997, 26, 769-775. [CrossRef] [PubMed]
14. Shrubsole, M.J.; Lu, W.; Chen, Z.; Shu, X.O.; Zheng, Y.; Dai, Q.; Cai, Q.; Gu, K.; Ruan, Z.X.; Gao, Y.T. et al. Drinking Green Tea Modestly Reduces Breast Cancer Risk. J. Nutr. 2009, 139, 310-316. [CrossRef] [PubMed]
15. Ganmaa, D.; Willett, W.C.; Li, T.Y.; Feskanich, D.; Dam, R.M.V.; Lopez-Garcia, E.; Hunter, D.J.; Holmes, M.D. Coffee, tea, caffeine and risk of breast cancer: A 22-year follow-up. Int. J. Cancer 2008, 122, 2071-2076. [CrossRef] [PubMed]
16. Dai, Q.; Shu, X.O.; Li, H.L.; Yang, G.; Shrubsole, M.J.; Cai, H.; Wen, W.Q.; Franke, A.; Gao, Y.T.; Zheng, W. Is green tea drinking associated with a later onset of breast cancer? Ann. Epidemiol. 2010, 20, 74-81. [CrossRef] [PubMed]
17. Zhang, M.; Huang, J.; Xie, X.; Holman, C.D.A.J. Dietary intakes of mushrooms and green tea combine to reduce the risk of breast cancer in Chinese women. Int. J. Cancer 2009, 124, 1404-1408. [CrossRef] [PubMed]
18. Wu, A.H.; Yu, M.C.; Tseng, C.C.; Hankin, J.; Pike, M.C. Green tea and risk of breast cancer in Asian Americans. Int. J. Cancer 2003, 106, 574-579. [CrossRef] [PubMed]
19. Wu, A.H.; Yu, M.C.; Tseng, C.C.; Pike, M.C. Body size, hormone therapy and risk of breast cancer in Asian-American women. Int. J. Cancer 2007, 120, 844-852. [CrossRef] [PubMed]
20. Kumar, N.; Titus-Ernstoff, L.; Newcomb, P.A.; Trentham-Dietz, A.; Anic, G.; Egani, K.M. Tea consumption and risk of breast cancer. Cancer Epidemiol. Biomark. 2009, 18, 341-345. [CrossRef] [PubMed]
21. Yuan, J.M.; Koh, W.P.; Sun, C.L.; Lee, J.P.; Yu, M.C. Green tea intake, ACE gene polymorphism and breast cancer risk among Chinese women in Singapore. Carcinogenesis 2005, 26, 1389-1394. [CrossRef] [PubMed]
22. Inoue, M.; Robien, K.; Wang, R.; Berg, D.J.V.D.; Koh, W.P.; Yu, M.C. Green tea intake, MTHFR/TYMS genotype and breast cancer risk: The Singapore Chinese Health Study. Carcinogenesis 2008, 29, 1967-1972. [CrossRef] [PubMed]
23. Ogunleye, A.A.; Xue, F.; Michels, K.B. Green tea consumption and breast cancer risk or recurrence: A meta-analysis. Breast Cancer Res. Treat. 2010, 119, 477-484. [CrossRef] [PubMed]
24. Guyton, K.Z.; Kensler, T.W. Oxidative mechanisms in carcinogenesis. Br. Med. Bull. 1993, 49, 523-544. [PubMed]
25. Rathore, K.; Choudhary, S.; Odoi, A.; Wang, H.C.R. Green tea catechin intervention of reactive oxygen species-mediated ERK pathway activation and chronically induced breast cell carcinogenesis. Carcinogenesis 2012, 33, 174-183. [CrossRef] [PubMed]
26. Ruch, R.J.; Cheng, S.J.; Klaunig, J.E. Prevention of cytotoxicity and inhibition of intercellular communication by antioxidant catechins isolated from Chinese green tea. Carcinogenesis 1989, 10, 1003-1008. [CrossRef] [PubMed]
27. Kaur, S.; Greaves, P.; Cooke, D.N.; Edwards, R.; Steward, W.P.; Gescher, A.J.; Marczylo, T.H. Breast cancer prevention by green tea catechins and black tea theaflavins in the C3(1) SV40 T,t antigen transgenic mouse model is accompanied by increased apoptosis and a decrease in oxidative DNA adducts. J. Agric. Food Chem. 2007, 55, 3378-3385. [CrossRef] [PubMed]
28. Parvez, S.; Tabassum, H.; Rehman, H.; Banerjee, B.D.; Athar, M.; Raisuddin, S. Catechin prevents tamoxifen-induced oxidative stress and biochemical perturbations in mice. Toxicology 2006, 225, 109-118. [CrossRef] [PubMed]
29. Abrahim, N.N.; Kanthimathi, M.S.; Abdul-Aziz, A. Piper betle shows antioxidant activities, inhibits MCF-7 cell proliferation and increases activities of catalase and superoxide dismutase. BMC Complement. Altern. Med. 2012, 12, 220-230. [CrossRef] [PubMed]
30. De Oliveira, M.R.; Nabavi, S.F.; Daglia, M.; Rastrell, L. Epigallocatechin gallate and mitochondria—A story of life and death. Pharmacol. Res. 2016, 104, 70-85. [CrossRef] [PubMed]
31. Van Aller, G.S.; Carson, J.D.; Tang, W.; Peng, H.; Zhao, L.; Copeland, R.A.; Tummino, P.J.; Luo, L. Epigallocatechingallate (EGCG), a major component of green tea, is a dual phosphoinositide-3-kinase/mTOR inhibitor. Biochem. Biophys. Res. Commun. 2011, 406, 194-199. [CrossRef] [PubMed]
32. Pan, M.H.; Lin, C.C.; Lin, J.K.; Chen, W.J. Tea polyphenol (−)-epigallocatechin 3-gallate suppresses heregulin-beta 1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling. J. Agric. Food Chem. 2007, 55, 5030-5037. [CrossRef] [PubMed]
33. Kim, J.Y.; Zhang, X.W.; Rieger-Christ, K.M.; Summerhayes, I.C.; Wazer, D.E.; Paulson, K.E.; Yee, A.S. Suppression of Wnt signaling by the green tea compound (−)-epigallocatechin 3-gallate (EGCG) in invasive breast cancer cells-Requirement of the transcriptional repressor HBP1. J. Biol. Chem. 2006, 281, 10865-10875. [CrossRef] [PubMed]
34. Bigelow, R.L.H.; Cardelli, J.A. The green tea catechins, (−)-epigallocatechin-3-gallate (EGCG) and (−)-epicatechin-3-gallate (ECG), inhibit HGF/Met signaling in immortalized and tumorigenic breast epithelial cells. Oncogene 2006, 25, 1922-1930. [CrossRef] [PubMed]
35. Pike, M.C.; Spicer, D.V.; Dahmoush, L.; Press, M.F. Estrogens, progestogens, normal breast cell-proliferation, and breast-cancer risk. Epidemiol. Rev. 1992, 15, 17-35.
36. Haldosen, L.A.; Zhao, C.Y.; Dahlman-Wright, K. Estrogen receptor beta in breast cancer. Mol. Cell. Endocrinol. 2014, 382, 665-672. [CrossRef] [PubMed]
37. Heldring, N.; Pike, A.; Andersson, S.; Matthews, J.; Cheng, G.; Hartman, J.; Tujague, M.; Strom, A.; Treuter, E.; Warner, M. et al. Estrogen receptors: How do they signal and what are their targets. Physiol. Rev. 2007, 87, 905-931. [CrossRef] [PubMed]
38. Kuruto-Niwa, R.; Inoue, S.; Ogawa, S.; Muramatsu, M.; Nozawa, R. Effects of tea catechins on the ERE-regulated estrogenic activity. J. Agric. Food Chem. 2000, 48, 6355-6361. [CrossRef] [PubMed]
39. Goodin, M.G.; Fertuck, K.C.; Zacharewski, T.R.; Rosengren, R.J. Estrogen receptor-mediated actions of polyphenoliccatechins in vivo and in vitro. Toxicol. Sci. 2002, 69, 354-361. [CrossRef] [PubMed]
40. Li, Y.Y.; Yuan, Y.Y.; Meeran, S.M.; Tollefsbol, T.O. Synergistic epigenetic reactivation of estrogen receptor-alpha (ERα) by combined green tea polyphenol and histone deacetylase inhibitor in ER alpha-negative breast cancer cells. Mol. Cancer 2010, 9, 274. [CrossRef] [PubMed]
41. Shim, J.H.; Choi, H.S.; Pugliese, A.; Lee, S.Y.; Chae, J.I.; Choi, B.Y.; Bode, A.M.; Dong, Z. (−)-Epigallocatechin gallate regulates CD3-mediated T cell receptor signaling in leukemia through the inhibition of ZAP-70 kinase. J. Biol. Chem. 2008, 283, 28370-28379. [CrossRef] [PubMed]
42. Umeda, D.; Yano, S.; Yamada, K.; Tachibana, H. Green tea polyphenol epigallocatechin-3-gallate signaling pathway through 67-kDa laminin receptor. J. Biol. Chem. 2008, 283, 3050-3058. [CrossRef] [PubMed]
43. Shim, J.H.; Su, Z.Y.; Chae, J.I.; Kim, D.J.; Zhu, F.; Ma, W.Y.; Bode, A.M.; Yang, C.S.; Dong, Z. Epigallocatechin gallate suppresses lung cancer cell growth through Ras-GTPase-activating protein SH3 domain-binding protein 1. Cancer Prev. Res. (Phila) 2010, 3, 670-679. [CrossRef] [PubMed]
44. Li, M.; He, Z.; Ermakova, S.; Zheng, D.; Tang, F.; Cho, Y.Y.; Zhu, F.; Ma, W.Y.; Sham, Y.; Rogozin, E.A. et al. Direct inhibition of insulin-like growth factor-I receptor kinase activity by (−)-epigallocatechin-3-gallate regulates cell transformation. Cancer Epidemiol. Biomark. Prev. 2007, 16, 598-605. [CrossRef] [PubMed]
45. Ermakova, S.; Choi, B.Y.; Choi, H.S.; Kang, B.S.; Bode, A.M.; Dong, Z. The intermediate filament protein vimentin is a new target for epigallocatechin gallate. J. Biol. Chem. 2005, 280, 16882-16890. [CrossRef] [PubMed]
46. Leone, M.; Zhai, D.; Sareth, S.; Kitada, S.; Reed, J.C.; Pellecchia, M. Cancer prevention by tea polyphenols is linked to their direct inhibition of antiapoptotic Bcl-2-family proteins. Cancer Res. 2003, 63, 8118-8121. [PubMed]
47. Ermakova, S.P.; Kang, B.S.; Choi, B.Y.; Choi, H.S.; Schuster, T.F.; Ma, W.Y.; Bode, A.M.; Dong, Z. (-)-Epigallocatechin gallate overcomes resistance to etoposide-induced cell death by targeting the molecular chaperone glucose-regulated protein 78. Cancer Res. 2006, 66, 9260-9269. [CrossRef] [PubMed]
48. He, Z.; Tang, F.; Ermakova, S.; Li, M.; Zhao, Q.; Cho, Y.Y.; Ma, W.Y.; Choi, H.S.; Bode, A.M.; Yang, C.S. et al. Fyn is a novel target of (−)-epigallocatechin gallate in the inhibition of JB6 Cl41 cell transformation. Mol. Carcinog. 2008, 47, 172-183. [CrossRef] [PubMed]
49. Jones, P.A.; Takai, D. The role of DNA methylation in mammalian epigenetics. Science 2001, 293, 1068-1070. [CrossRef] [PubMed]
50. Lee, J.L.; Shim, J.Y.; Zhu, B.T. Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids. Mol. Pharmacol. 2005, 68, 1018-1030. [CrossRef] [PubMed]
51. Fang, M.Z.; Wang, Y.; Ai, N.; Hou, Z.; Sun, Y.; Lu, H.; Welsh, W.; Yang, C.S. Tea polyphenol (−)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res. 2003, 63, 7563-7570. [PubMed]
52. Huo, C.; Yang, H.; Cui, Q.C.; Dou, Q.P.; Chan, T.H. Proteasome inhibition in human breast cancer cells with high catechol-o-methyltransferase activity by green tea polyphenol EGCG analog. Bioorg. Med. Chem. 2010, 18, 1252-1258. [CrossRef] [PubMed]
53. Landis-Piwowar, K.R.; Wan, S.B.; Wiegand, R.A.; Kuhn, D.J.; Chan, T.H.; Dou, Q.P. Methylation suppresses the proteasome-inhibitory function of green tea polyphenols. J. Cell. Physiol. 2007, 213, 256-260. [CrossRef] [PubMed]
54. Landis-Piwowar, K.R.; Chen, D.I.; Chan, T.H.; Dou, Q.P. Inhibition of catechol-O-methyltransferase activity in human breast cancer cells enhances the biological effect of the green tea polyphenol (−)-EGCG. Oncol. Rep. 2010, 24, 563-569. [PubMed]
55. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1995, 1, 27-31. [CrossRef] [PubMed]
56. Ferrara, N.; Davis-Smyth, T. The biology of vascular endothelial growth factor. Endocr. Rev. 1997, 18, 4-25. [CrossRef] [PubMed]
57. Mukhtar, H.; Katiyar, S.K.; Agarwal, R. Green tea and skin-anticarcinogenic effects. J. Invest. Dermatol. 1994, 102, 3-7. [CrossRef] [PubMed]
58. Stoner, G.D.; Mukhtar, H. Polyphenols as cancer chemopreventive agents. J. Cell. Biochem. 1995, 22, 169-180. [CrossRef]
59. Tang, F.Y.; Meydani, M. Green tea catechins and vitamin E inhibit angiogenesis of human microvascular endothelial cells through suppression of IL-8 production. Nutr. Cancer 2001, 41, 119-125. [CrossRef] [PubMed]
60. Maryam, R.S.; Shao, Z.M.; David, H. Green tea inhibits vascular endothelial growth factor (VEGF) induction inhuman breast cancer cells. J. Nutr. 2002, 132, 2307-2311.
61. Shaun, K.R.; Guo, W.M.; Liu, L.P. Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex. J. Cancer 2006, 118, 1635-1644.
62. Seeram, N.P.; Zhang, Y.; Nair, M.G. Inhibition of proliferation of human cancer cells and cyclooxygenase enzymes by anthocyanidins and catechins. Nutr. Cancer 2003, 46, 101-106. [CrossRef] [PubMed]
63. Deguchi, H.; Fujii, T.; Nakagawa, S.; Koga, T.; Shirouzu, K. Analysis of cell growth inhibitory effects of catechin through MAPK in human breast cancer cell line T47D. Int. J. Oncol. 2002, 21, 1301-1305. [CrossRef] [PubMed]
64. Alshatwi, A.A. Catechin hydrate suppresses MCF-7 proliferation through TP53/Caspase-mediated apoptosis. J. Exp. Clin. Canc. Res. 2010, 29, 2-9. [CrossRef] [PubMed]
65. Afsar, T.; Trembley, J.H.; Salomon, C.E.; Razak, S.; Khan, M.R.; Ahmed, K. Growth inhibition and apoptosis in cancer cells induced by polyphenolic compounds of Acacia hydaspica: Involvement of multiple signal transduction pathways. Sci. Rep. 2016, 6, 23077. [CrossRef] [PubMed]
66. Jo, E.H.; Lee, S.J.; Ahn, N.S.; Park, J.S.; Hwang, J.W.; Kim, S.H.; Aruoma, O.I.; Lee, Y.S.; Kang, K.S. Induction of apoptosis in MCF-7 and MDA-MB-231 breast cancer cells by Oligonol is mediated by Bcl-2 family regulation and MEK/ERK signaling. Eur. J. Cancer Prev. 2007, 16, 342-347. [CrossRef] [PubMed]
67. Nifli, A.P.; Kampa, M.; Alexaki, V.I.; Notas, G.; Castanas, E. Polyphenol interaction with the T47D human breast cancer cell line. J. Dairy Res. 2005, 72, 44-50. [CrossRef] [PubMed]
68. Palmer, A.E.; Jin, C.; Reed, J.C.; Tsien, R.Y. Bcl-2-Mediated alterations in endoplasmic reticulum Ca2t analyzed with an improved genetically encoded fluorescent sensor. Proc. Natl. Acad. Sci. USA 2004, 101, 17404-17409. [CrossRef] [PubMed]
69. Hsu, Y.C.; Liou, Y.M. The Anti-cancer effects of (−)-epigalocathine-3-gallate on the signaling pathways associated with membrane receptors in MCF-7 cells. J. Cell. Physiol. 2011, 226, 2721-2730. [CrossRef] [PubMed]
70. Luo, K.; Koa, C.H.; Yue, G.G.L.; Lee, J.K.M.; Li, K.K.; Lee, M.; Li, G.; Fung, K.P.; Leung, P.C.; Lau, C.B.S. Green tea (Camellia sinensis) extract inhibits both the metastasis and osteolytic components of mammary cancer 4T1 lesions in mice. J. Nutr. Biochem. 2014, 25, 395-403. [CrossRef] [PubMed]
71. Slivova, V.; Zaloga, G.; DeMichele, S.J.; Mukerji, P.; Huang, Y.S.; Siddiqui, R.; Harvey, K.; Valachovicova, T.; Sliva, D. Green tea polyphenols modulate secretion of urokinase plasminogen activator (uPA) and inhibit invasive behavior of breast cancer cells. Nutr. Cancer 2005, 52, 66-73. [CrossRef] [PubMed]
72. Zhang, Y.; Han, G.; Fan, B.; Zhou, Y.; Zhou, X.; Wei, L.; Zhang, J. Green tea (−)-epigallocatechin-3-gallate down-regulates VASP expression and inhibits breast cancer cell migration and invasion by attenuating Rac1 activity. Eur. J. Pharmacol. 2009, 606, 172-179. [CrossRef] [PubMed]
73. Annabi, B.; Lachambre, M.P.; Bousquet-Gagnon, N.; Page, M.; Gingras, D.; Beliveau, R. Green tea polyphenol (−)-epigallocatechin 3-gallate inhibits MMP-2 secretion and MT1-MMP-driven migration in glioblastoma cells. Biochim. Biophys. Acta 2002, 1542, 209-220. [CrossRef]
74. Sen, T.; Chatterjee, A. Epigallocatechin-3-gallate (EGCG) downregulates EGF-induced MMP-9 in breast cancer cells: Involvement of integrin receptor alpha 5 beta 1 in the process. Eur. J. Nutr. 2011, 50, 465-478. [CrossRef] [PubMed]
75. Xiaokaiti, Y.; Wu, H.M.; Chen, Y.; Yang, H.P.; Duan, J.H.; Li, X.; Pan, Y.; Tie, L.; Zhang, L.R.; Li, X.J. EGCG reverses human neutrophil elastase-induced migration in A549 cells by directly binding to HNE and by regulating alpha1-AT. Sci. Rep. 2015, 5, 11494. [CrossRef] [PubMed]
76. Farabegoli, F.; Papi, A.; Orlandi, M. (−)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells. Biosci. Rep. 2010, 31, 99-108. [CrossRef] [PubMed]
77. Zhou, P.; Li, J.P.; Zhang, C. Green tea consumption and breast cancer risk: Three recent meta-analyses. Breast Cancer Res. Treat. 2011, 127, 581-582. [CrossRef] [PubMed]
78. Ogunleye, A.A.; Xue, F.; Michels, K.B. Green tea consumption and breast cancer risk: Three recent meta-analyses Rebuttal. Breast Cancer Res. Treat. 2011, 127, 583.
79. Baker, J.A.; Beehler, G.P.; Sawant, A.C.; Jayaprakash, V.; McCann, S.E.; Moysich, K.B. Consumption of coffee, but not black tea, is associated with decreased risk of premenopausal breast cancer. J. Nutr. 2006, 136, 166-171. [PubMed]
80. Rosenblatt, K.A.; Thomas, D.B.; Jimenez, L.M.; Fish, B.; McTiernan, A.; Stalsberg, H.; Stemhagen, A.; Thompson, W.D.; Curnen, M.G.M.; Satariano, W. et al. The relationship between diet and breast cancer in men (United States). Cancer Cause Control 1999, 10, 107-113. [CrossRef]
81. Weng, Z.; Greenhaw, J.; Salminen, W.F.; Shi, Q. Mechanisms for epigallocatechin gallate induced inhibition of drug metabolizing enzymes in rat liver microsomes. Toxicol. Lett. 2012, 214, 328-338. [CrossRef] [PubMed]
82. Lorenz, M.; Paul, F.; Moobed, M.; Baumann, G.; Zimmermann, B.F.; Stangl, K.; Stangl, V. The activity of catechol-O-methyltransferase (COMT) is not impaired by high doses of epigallocatechin-3-gallate (EGCG) in vivo. Eur. J. Pharmacol. 2014, 740, 645-651. [CrossRef] [PubMed]
83. Suganuma, M.; Okabe, S.; Sueoka, N.; Sueoka, E.; Matsuyama, S.; Imai, K.; Nakachi, K.; Fujiki, H. Green tea and cancer chemoprevention. Mutat. Res. 1999, 428, 339-344. [CrossRef]
84. Forester, S.C.; Lambert, J.D. The catechol-O-methyltransferase inhibitor, tolcapone, increases the bioavailability of unmethylated (−)-epigallocatechin-3-gallate in mice. J. Funct. Foods 2015, 17, 183-188. [CrossRef] [PubMed]
85. Krupkova, O.; Ferguson, S.J.; Wuertz-Kozak, K. Stability of (−)-epigallocatechin gallate and its activity in liquid formulations and delivery systems. J. Nutr. Biochem. 2016, 37, 1-12. [CrossRef]
86. Dube, A.; Nicolazzo, J.A.; Larson, I. Chitosan nanoparticles enhance the intestinal absorption of the green tea catechins (+)-catechin and (−)-epigallocatechingallate. Eur. J. Pharm. Sci. 2014, 41, 219-225. [CrossRef] [PubMed]
87. Yadav, R.; Kumar, D.; Kumari, A.; Yadav, S.K. Encapsulation of catechin and epicatechin on BSA NPs improved their stability and antioxidant potential. EXCLI J. 2014, 13, 331-346. [PubMed]
88. Liang, J.; Cao, L.; Zhang, L.; Wan, X. Preparation, characterization, and in vitro antitumor activity of folate conjugated chitosan coated EGCG nanoparticles. Food Sci. Biotechnol. 2014, 23, 569-575. [CrossRef]
89. Fangueiro, J.F.; Calpena, A.C.; Clares, B.; Andreani, T.; Egea, M.A.; Veiga, F.J.; Garcia, M.L.; Silva, A.M.; Souto, E.B. Biopharmaceutical evaluation of epigallocatechin gallate-loaded cationic lipid nanoparticles (EGCG-LNs): In vivo, in vitro and ex vivo studies. Int. J. Pharm. 2016, 502, 161-169. [CrossRef] [PubMed]
90. Tagashira, T.; Choshi, T.; Hibino, S.; Kamishikiryou, J.; Sugihara, N. Influence of gallate and pyrogallol moieties on the intestinal absorption of (−)-epicatechin and (−)-epicatechingallate. J. Food Sci. 2012, 77, H208-H215. [CrossRef] [PubMed]
91. Naumovski, N.; Blades, B.L.; Roach, P.D. Food inhibits the oral bioavailability of the major green tea antioxidant epigallocatechingallate in humans. Antioxidants 2015, 4, 373-393. [CrossRef] [PubMed]
92. Son, Y.R.; Chung, J.H.; Ko, S.; Shim, S.M. Combinational enhancing effects of formulation and encapsulation on digestive stability and intestinal transport of green tea catechins. J. Microencapsul. 2016, 33, 183-190. [CrossRef] [PubMed]
93. Aditya, N.P.; Aditya, S.; Yang, H.; Kim, H.W.; Park, S.O.; Ko, S. Co-Delivery of hydrophobic curcumin and hydrophilic catechin by a water-in-oil-in-water double emulsion. Food Chem. 2015, 173, 7-13. [CrossRef] [PubMed]
94. Garcia, J.P.D.; Hsieh, M.F.; Doma, B.T.; Peruelo, D.C.; Chen, I.H.; Lee, H.M. Synthesis of gelatin--polyglutamic acid-based hydrogel for the in vitro controlled release of epigallocatechin gallate (EGCG) from Camellia sinensis. Polymers 2014, 6, 39-58. [CrossRef]